Cargando…
Integrated analysis of NET‐DNA receptor CCDC25 in malignant tumors: Pan‐cancer analysis
BACKGROUND: Previously, it was reported that the coiled‐coil domain containing 25 (CCDC25) plays a role in the formation of neutrophil extracellular traps (NETs). This study systematically analyzed the expression profiles of CCDC25 in 30 different types of cancer and one type of blood cancer, acute...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568976/ https://www.ncbi.nlm.nih.gov/pubmed/37841944 http://dx.doi.org/10.1002/hsr2.1621 |
_version_ | 1785119468691652608 |
---|---|
author | Cheng, Xianlin Yin, Xinhai Song, Jukun |
author_facet | Cheng, Xianlin Yin, Xinhai Song, Jukun |
author_sort | Cheng, Xianlin |
collection | PubMed |
description | BACKGROUND: Previously, it was reported that the coiled‐coil domain containing 25 (CCDC25) plays a role in the formation of neutrophil extracellular traps (NETs). This study systematically analyzed the expression profiles of CCDC25 in 30 different types of cancer and one type of blood cancer, acute myeloid leukemia. METHODS: The GTEx and CCLE databases were used to evaluate the distribution of CCDC25 expression in both normal tissue and cancer cell lines. A comparison was performed between normal tissue and tumor tissue to analyze the differential expression of CCDC25. We assessed the impact of CCDC25 on the clinical outlook in the TCGA pan‐cancer data set by analyzing the Kaplan–Meier survival plot and conducting COX regression analysis. Moreover, the association between the expression levels of CCDC25 and the tumor microenvironment in multiple cancers was conducted. Additionally, the investigation also examined the link between CCDC25 and immune neoantigen, tumor mutational burden, microsatellite instability, mismatch repair genes (MMRs), HLA‐related genes, and DNA methyltransferase (DNMT). RESULTS: CCDC25 was expressed in nearly all of the 31 normal tissues while exhibiting a moderate to low level of expression in cancer cell lines. While abnormal expression was detected in the majority of malignancies, there was no link found between elevated CCDC25 levels and overall survival, disease‐free survival, recurrence‐free survival, and disease‐free interval in the TCGA comprehensive cancer data set. Nevertheless, the expression of CCDC25 exhibited a notable link with the infiltration levels of activated CD4 memory T cells, quiescent mast cells, dendritic cells in an activated state, T cells that assist in follicle development, M2 macrophages, and neutrophils in various tumors. CONCLUSIONS: In most cancers, the results indicate that there is no link between CCDC25 and prognosis. However, CCDC25 can be targeted for therapeutic purposes concerning metastasis and immune infiltration. |
format | Online Article Text |
id | pubmed-10568976 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105689762023-10-13 Integrated analysis of NET‐DNA receptor CCDC25 in malignant tumors: Pan‐cancer analysis Cheng, Xianlin Yin, Xinhai Song, Jukun Health Sci Rep Original Research BACKGROUND: Previously, it was reported that the coiled‐coil domain containing 25 (CCDC25) plays a role in the formation of neutrophil extracellular traps (NETs). This study systematically analyzed the expression profiles of CCDC25 in 30 different types of cancer and one type of blood cancer, acute myeloid leukemia. METHODS: The GTEx and CCLE databases were used to evaluate the distribution of CCDC25 expression in both normal tissue and cancer cell lines. A comparison was performed between normal tissue and tumor tissue to analyze the differential expression of CCDC25. We assessed the impact of CCDC25 on the clinical outlook in the TCGA pan‐cancer data set by analyzing the Kaplan–Meier survival plot and conducting COX regression analysis. Moreover, the association between the expression levels of CCDC25 and the tumor microenvironment in multiple cancers was conducted. Additionally, the investigation also examined the link between CCDC25 and immune neoantigen, tumor mutational burden, microsatellite instability, mismatch repair genes (MMRs), HLA‐related genes, and DNA methyltransferase (DNMT). RESULTS: CCDC25 was expressed in nearly all of the 31 normal tissues while exhibiting a moderate to low level of expression in cancer cell lines. While abnormal expression was detected in the majority of malignancies, there was no link found between elevated CCDC25 levels and overall survival, disease‐free survival, recurrence‐free survival, and disease‐free interval in the TCGA comprehensive cancer data set. Nevertheless, the expression of CCDC25 exhibited a notable link with the infiltration levels of activated CD4 memory T cells, quiescent mast cells, dendritic cells in an activated state, T cells that assist in follicle development, M2 macrophages, and neutrophils in various tumors. CONCLUSIONS: In most cancers, the results indicate that there is no link between CCDC25 and prognosis. However, CCDC25 can be targeted for therapeutic purposes concerning metastasis and immune infiltration. John Wiley and Sons Inc. 2023-10-12 /pmc/articles/PMC10568976/ /pubmed/37841944 http://dx.doi.org/10.1002/hsr2.1621 Text en © 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Cheng, Xianlin Yin, Xinhai Song, Jukun Integrated analysis of NET‐DNA receptor CCDC25 in malignant tumors: Pan‐cancer analysis |
title | Integrated analysis of NET‐DNA receptor CCDC25 in malignant tumors: Pan‐cancer analysis |
title_full | Integrated analysis of NET‐DNA receptor CCDC25 in malignant tumors: Pan‐cancer analysis |
title_fullStr | Integrated analysis of NET‐DNA receptor CCDC25 in malignant tumors: Pan‐cancer analysis |
title_full_unstemmed | Integrated analysis of NET‐DNA receptor CCDC25 in malignant tumors: Pan‐cancer analysis |
title_short | Integrated analysis of NET‐DNA receptor CCDC25 in malignant tumors: Pan‐cancer analysis |
title_sort | integrated analysis of net‐dna receptor ccdc25 in malignant tumors: pan‐cancer analysis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568976/ https://www.ncbi.nlm.nih.gov/pubmed/37841944 http://dx.doi.org/10.1002/hsr2.1621 |
work_keys_str_mv | AT chengxianlin integratedanalysisofnetdnareceptorccdc25inmalignanttumorspancanceranalysis AT yinxinhai integratedanalysisofnetdnareceptorccdc25inmalignanttumorspancanceranalysis AT songjukun integratedanalysisofnetdnareceptorccdc25inmalignanttumorspancanceranalysis |